GoodRx CEO Sees Endless Opportunities for GLP-1s

The transcript covers an interview discussing the speaker's background and its relevance to leading GoodRx. It explains GoodRx's business model, including partnerships with pharmacies and pharma manufacturers, and how it generates revenue. The discussion also touches on challenges like drug shortages and opportunities in cash pricing. Potential regulatory changes and their impact on GoodRx are considered, along with strategies to regain investor confidence and future growth prospects.

How does GoodRx help consumers navigate drug affordability programs?

What potential changes in regulations does the speaker anticipate affecting GoodRx?

What message does the speaker want to convey to investors regarding GoodRx's future?